Mads Clausen
Chairman
Ophthalmology
MC2 Therapeutics
Denmark
Biography
Mads Clausen led the establishment of MC2 Therapeutics and serves as Chairman of the Board. Mr. Clausen is also Executive Chairman of Applied Biomimetic Inc. (USA), a privately held developer of novel high-performance membrane technology. Further to this, he serves as a Director of the Board of the Bitten and Mads Clausen Foundation (Denmark). Mr. Clausen holds a MS in Engineering from the Technical University of Denmark, MS in Biotechnology from The Johns Hopkins University and an MBA from the London Business School.
Research Interest
Ophthalmology
